RankingsPricing
  1. JP-listed companies
  2. Mochida Pharmaceutical Co.,Ltd.
  3. Financials
  4. Capital expenditures

Mochida Pharmaceutical Co.,Ltd.【JP:4534】

Market cap
¥135.6B
P/E ratio
24.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-2,160-5.92%
Mar 31, 2024-2,296+6.00%
Mar 31, 2023-2,166-27.51%
Mar 31, 2022-2,988+54.42%
Mar 31, 2021-1,935-1.17%
Mar 31, 2020-1,958+43.13%
Mar 31, 2019-1,368+24.93%
Mar 31, 2018-1,095-0.99%
Mar 31, 2017-1,106-39.46%
Mar 31, 2016-1,827-5.34%
Mar 31, 2015-1,930

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)